CR7481A - Procedimientos de preparacion de combretastatinas - Google Patents

Procedimientos de preparacion de combretastatinas

Info

Publication number
CR7481A
CR7481A CR7481A CR7481A CR7481A CR 7481 A CR7481 A CR 7481A CR 7481 A CR7481 A CR 7481A CR 7481 A CR7481 A CR 7481A CR 7481 A CR7481 A CR 7481A
Authority
CR
Costa Rica
Prior art keywords
combretastatinas
procedures
preparation
phosphonium salt
wittig
Prior art date
Application number
CR7481A
Other languages
English (en)
Inventor
Stephane Mutti
Michel Lavigne
Irina Malejonock
Jean-Paul Casimir
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of CR7481A publication Critical patent/CR7481A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Catalysts (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Magnetic Ceramics (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Detergent Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

La invencion se refiere a nuevos procedimientos de preparacion de combretastatinas mediante condensacion de Wittig entre nitrometoxi-benzaldehido y una sal de trimetoxibencil-fosfonio o inversamente una sal de nitrometoxibencil-fosfonio con trimetoxi-benzaldehido o ademas mediante una reaccion de Wittig sobre los mismos derivados, en la que la funcion nitro se ha reducido a un grupo amino.
CR7481A 2002-04-11 2004-09-14 Procedimientos de preparacion de combretastatinas CR7481A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0204499A FR2838437B1 (fr) 2002-04-11 2002-04-11 Procedes de preparation de combretastatines

Publications (1)

Publication Number Publication Date
CR7481A true CR7481A (es) 2008-11-25

Family

ID=28459732

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7481A CR7481A (es) 2002-04-11 2004-09-14 Procedimientos de preparacion de combretastatinas

Country Status (27)

Country Link
EP (3) EP2354118A1 (es)
JP (1) JP4299677B2 (es)
KR (1) KR101018983B1 (es)
CN (1) CN1291970C (es)
AR (2) AR039198A1 (es)
AU (1) AU2003260026B2 (es)
BR (1) BR0309087A (es)
CA (1) CA2481742C (es)
CR (1) CR7481A (es)
EA (1) EA007965B1 (es)
EC (1) ECSP045348A (es)
FR (1) FR2838437B1 (es)
HR (1) HRP20040935A2 (es)
IL (1) IL164247A0 (es)
MA (1) MA26407A1 (es)
ME (1) MEP91508A (es)
MX (1) MXPA04009112A (es)
NO (2) NO329701B1 (es)
NZ (1) NZ535318A (es)
OA (1) OA12804A (es)
PL (3) PL214129B1 (es)
RS (3) RS20110561A3 (es)
TN (1) TNSN04201A1 (es)
TW (1) TWI262179B (es)
UA (1) UA76079C2 (es)
WO (1) WO2003084919A2 (es)
ZA (1) ZA200407417B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235688B1 (en) 2004-11-04 2007-06-26 University Of Notre Dame Du Lac Process for preparing histone deacetylase inhibitors and intermediates thereof
FR2928148B1 (fr) * 2008-02-28 2013-01-18 Sanofi Aventis Procede de preparation de combretastatine
FR2939665B1 (fr) 2008-12-12 2011-10-07 Sanofi Aventis Combinaison antitumorale associant l'ave8062a et le docetaxel
FR2945210B1 (fr) 2009-05-07 2011-07-01 Sanofi Aventis Combinaison antitumorale comprenant l'ave8062 et le sorafenib
FR2953518B1 (fr) 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
CA2802974A1 (en) 2010-06-18 2011-12-22 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2481404A1 (en) 2010-11-15 2012-08-01 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2397135A1 (en) 2010-06-18 2011-12-21 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2407161A1 (en) 2010-07-13 2012-01-18 Sanofi An antitumoral combination comprising ombrabulin and bevacizumab
FR2968557A1 (fr) 2010-12-09 2012-06-15 Sanofi Aventis Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab
FR2978662A1 (fr) 2011-08-01 2013-02-08 Sanofi Sa Combinaison antitumorale comprenant l'ombrabuline et le cisplatine, associee a la radiotherapie
FR2978663A1 (fr) 2011-08-01 2013-02-08 Sanofi Sa Combinaison antitumorale comprenant l'ombrabuline et le cetuximab, associee a la radiotherapie
CN103012248B (zh) * 2013-01-11 2014-11-05 浙江大德药业集团有限公司 氨基康普立停衍生物的合成及其作为口服抗肿瘤药物的应用
EP2805705B1 (en) 2013-05-23 2016-11-09 IP Gesellschaft für Management mbH Packaging with one or more administration units comprising a sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1 H-imidazol-4-yl)-propionic acid
EP4079327A1 (en) 2021-04-22 2022-10-26 Centaurus Polytherapeutics Payloads for drug-conjugates and their use for treating cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996237A (en) 1987-01-06 1991-02-26 Arizona Board Of Regents Combretastatin A-4
SU1766257A3 (ru) * 1988-02-24 1992-09-30 Ф.Хоффманн-Ля Рош Аг (Фирма) Способ получени производных стильбена
NZ232897A (en) * 1989-04-03 1992-12-23 Squibb & Sons Inc Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogues, preparation and pharmaceutical compositions thereof
US5731353A (en) * 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
WO1995027699A1 (en) * 1994-04-06 1995-10-19 Nippon Shinyaku Co., Ltd. Aminostilbazole derivative and medicine
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
JP4551514B2 (ja) * 1999-07-23 2010-09-29 住友化学株式会社 不飽和炭化水素残基置換アニリン類の製造方法
GB9918912D0 (en) 1999-08-12 1999-10-13 Angiogene Pharm Ltd New stilbenes with vascular damaging activity

Also Published As

Publication number Publication date
RS52331B (sr) 2012-12-31
KR101018983B1 (ko) 2011-03-07
IL164247A0 (en) 2005-12-18
JP2005522478A (ja) 2005-07-28
KR20040108717A (ko) 2004-12-24
PL371629A1 (pl) 2005-06-27
EP2354118A1 (fr) 2011-08-10
TWI262179B (en) 2006-09-21
AU2003260026A1 (en) 2003-10-20
AR039198A1 (es) 2005-02-09
EP2348012A1 (fr) 2011-07-27
WO2003084919A2 (fr) 2003-10-16
OA12804A (fr) 2006-07-11
UA76079C2 (en) 2006-06-15
NO20044814L (no) 2004-01-07
EA007965B1 (ru) 2007-02-27
PL394821A1 (pl) 2011-09-12
ZA200407417B (en) 2006-04-26
NZ535318A (en) 2007-02-23
HRP20040935A2 (en) 2005-10-31
RS86504A (sr) 2007-02-05
EA200401350A1 (ru) 2005-02-24
PL213708B1 (pl) 2013-04-30
TW200401762A (en) 2004-02-01
TNSN04201A1 (fr) 2007-03-12
BR0309087A (pt) 2005-02-09
NO20101215L (no) 2004-01-07
RS20110561A2 (sr) 2012-10-31
MA26407A1 (fr) 2004-12-01
JP4299677B2 (ja) 2009-07-22
CN1291970C (zh) 2006-12-27
ECSP045348A (es) 2004-11-26
EP1497255A2 (fr) 2005-01-19
CA2481742A1 (fr) 2003-10-16
AU2003260026B2 (en) 2008-01-03
WO2003084919A3 (fr) 2004-04-08
HK1075651A1 (en) 2005-12-23
CA2481742C (fr) 2012-06-19
AR082581A2 (es) 2012-12-19
FR2838437B1 (fr) 2004-06-04
RS20110562A3 (en) 2013-12-31
NO331372B1 (no) 2011-12-12
NO329701B1 (no) 2010-12-06
RS20110561A3 (en) 2013-10-31
PL394820A1 (pl) 2011-09-12
MEP91508A (bs) 2011-12-20
RS20110562A2 (sr) 2012-10-31
PL214129B1 (pl) 2013-06-28
MXPA04009112A (es) 2004-12-07
CN1646476A (zh) 2005-07-27
FR2838437A1 (fr) 2003-10-17
PL213967B1 (pl) 2013-05-31

Similar Documents

Publication Publication Date Title
CR7481A (es) Procedimientos de preparacion de combretastatinas
HN2006019066A (es) "(s)-n-metilnaltrexona"
CR6895A (es) Nuevos compuestos heterociclicos su preparacion y su utilizacion como medicamentos en especial como antibacterianos
CR10156A (es) Metodos para preparar alcoholes sulfonamida sustituidos e intermediarios de estos
CR7995A (es) Nueva difenilazetidinona con caracteristicas fisiologicas mejoradas correspondiente metodo de produccion , medicamentos que lo contienen y uso de los mismos
ES2172303T3 (es) Agentes terapeuticos obtenidos por catalisis enzimatica.
GT200000152A (es) Envases de policarbonato ramificado, su fabricacion y su uso.
HN2002000300A (es) Nuevos derivados de piperazina
DE60210010D1 (de) Kollimationssystem für Laserdiode
UY27852A1 (es) Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
MXPA04000443A (es) Metodo novedoso para la sintesis de derivados del acido (2s, 3as, 7as)-1-[(s)-alanil]-octahidro-1h-indol-2-carboxilico y la aplicacion en la sintesis de perindopril.
NO20050019L (no) Polytylenglykolaldehyd-derivater
ES2101967T3 (es) Compuestos utilizables como productos de contraste en radiografia.
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
HN1998000167A (es) Nuevo procedimiento para preparar una cetoimina
NI200700227A (es) Procesos para la purificación de compuestos benzoxazol sustituidos.
MEP36808A (en) Ambroxol-containing lozenge
FR2817187B1 (fr) Cutter a porte-lame monobloc a fixation-liberation de la lame par pression
ECSP066291A (es) Sistemas emulsionantes que contienen derivados de azetidina
HN1999000101A (es) Inhibidores de las fkbp.
PA8469601A1 (es) Procedimiento para alquilar sulfonamidas impedidas estericamente
BR0101437A (pt) Método para preparar um ciclopropeno
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
ES2192021T3 (es) Procedimiento para preparar haluros de fenoxifenilo.
SV2002000320A (es) Proceso para la simple preparacion de (3-cloro-4- fluorofenilo)-[7-(3-morfolina-4ilo-propoxi)-6-nitroquinazolina-4ilo]-amina o (3-cloro-4-fluorofenilo-[7-(3-morfolina-4-il-propoxi)-6-aminoquinazolina-4-ilo]-amina ref.b.12187/rm/shh